Cargando…

Recalcitrant psoriasis responding to new bilogic drug: Ustekinumab

Detalles Bibliográficos
Autores principales:	Husein-ElAhmed, Husein, Molina-Leyva, Alejandro, Garrido-TorresPuchol, Valeriano, Ruiz-Carrascosa, Jose
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	King Faisal Specialist Hospital and Research Centre 2013
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074921/ https://www.ncbi.nlm.nih.gov/pubmed/24413873 http://dx.doi.org/10.5144/0256-4947.2013.632

Ejemplares similares

Case for diagnosis()
por: Leyva, Alejandro Molina, et al.
Publicado: (2014)

Sclerodermiform basal cell carcinoma: how much can we rely on dermatoscopy to differentiate from non-aggressive basal cell carcinomas? Analysis of 1256 cases
por: Husein-ElAhmed, Husein
Publicado: (2018)

Hidradenitis Suppurativa and Risk of Myocardial Infarction: A Plausible Association?
por: Husein-ElAhmed, Husein, et al.
Publicado: (2023)

Lower lip reconstruction using a skin-mucosa Abbe-Estlander flap after squamous cell carcinoma excision
por: Husein-ElAhmed, Husein, et al.
Publicado: (2017)

Dermatoscopy-guided therapy of pigmented basal cell carcinoma with imiquimod
por: Husein-ElAhmed, Husein, et al.
Publicado: (2016)

Ustekinumab-induced remission of recalcitrant guttate psoriasis: A case series
por: Brummer, Grace C., et al.
Publicado: (2017)

Vogt–Koyanagi–Harada Disease, a Rare Entity in Spain: The Challenge of Worldwide Immigration and Globalization
por: Fernández, Alberto Benavente, et al.
Publicado: (2018)

Treatment of recalcitrant disseminated ulcerative necrobiosis lipoidica with ustekinumab
por: McMullan, Patrick, et al.
Publicado: (2023)

Cutaneous Granular Cell Tumor of the Breast: A Clinical Diagnostic Pitfall
por: Aneiros-Fernandez, Jose, et al.
Publicado: (2010)

Ustekinumab for the treatment of recalcitrant pyoderma gangrenosum: A case report
por: Vallerand, Isabelle A, et al.
Publicado: (2019)

Distribution pattern of psoriasis, anxiety and depression as possible causes of sexual dysfunction in patients with moderate to severe psoriasis
por: Molina-Leyva, Alejandro, et al.
Publicado: (2015)

Ustekinumab: differential use in psoriasis
por: Uhlenhake, Elizabeth E, et al.
Publicado: (2011)

Widespread Eosinophilic Pustular Folliculitis in a Nonimmunocompromised Patient
por: Almodovar-Real, Ana, et al.
Publicado: (2014)

Ustekinumab in the therapy of chronic plaque psoriasis
por: O’Neill, Jenna L, et al.
Publicado: (2009)

Ustekinumab in the Treatment of Psoriasis and Psoriatic Arthritis
por: Savage, Laura J., et al.
Publicado: (2015)

Thyrotoxicosis Associated with Ustekinumab Treatment for Psoriasis
por: Olabi, Bayanne, et al.
Publicado: (2020)

Four years stability of type D personality in patients with moderate to severe psoriasis and its implications for psychological impairment()()
por: Aguayo-Carreras, Paula, et al.
Publicado: (2021)

Increased Skin Clearance and Quality of Life Improvement with Brodalumab Compared with Ustekinumab in Psoriasis Patients with Aggravating Lifestyle Factors
por: Kokolakis, Georgios, et al.
Publicado: (2021)

Paradoxical Flare of Psoriasis after Ustekinumab Therapy
por: Lee, Ho Yeol, et al.
Publicado: (2017)

Peritoneal tuberculosis in the setting of ustekinumab treatment for psoriasis
por: Lynch, Maeve, et al.
Publicado: (2017)

Real-world use of ustekinumab therapeutic drug monitoring in moderate to severe psoriasis
por: Elberdín, Laida, et al.
Publicado: (2022)

Potential role of ustekinumab in the treatment of chronic plaque psoriasis
por: Mercuri, Santo Raffaele, et al.
Publicado: (2010)

Emerging treatments in the management of psoriasis: biological targeting with ustekinumab
por: Papoutsaki, Marina, et al.
Publicado: (2009)

Association of Serum Ustekinumab Levels With Clinical Response in Psoriasis
por: Tsakok, Teresa, et al.
Publicado: (2019)

Genome-Wide Association Study of Ustekinumab Response in Psoriasis
por: Connell, William T., et al.
Publicado: (2022)

Toenail Psoriasis during Ustekinumab Therapy: Results and Limitations
por: Yang, Seungkeol, et al.
Publicado: (2021)

Integrated safety analysis of treatment‐emergent eczematous reactions in patients with moderate‐to‐severe psoriasis treated with ixekizumab, etanercept and ustekinumab
por: Brunner, P.M., et al.
Publicado: (2021)

Effects of Initial Values and Convergence Criterion in the Two-Parameter Logistic Model When Estimating the Latent Distribution in BILOG-MG 3
por: Nader, Ingo W., et al.
Publicado: (2015)

Comparative assessment of biologics in treatment of psoriasis: drug design and clinical effectiveness of ustekinumab
por: Garcia-Valladares, Ignacio, et al.
Publicado: (2011)

Ustekinumab: an evidence-based review of its effectiveness in the treatment of psoriasis
por: Krulig, Eliana, et al.
Publicado: (2010)

Challenging Regional Psoriasis and Ustekinumab Biotherapy: Impact of the Patterns of Disease
por: Hermanns-Lê, Trinh, et al.
Publicado: (2012)

Influence of ustekinumab on body weight of patients with psoriasis: an initial report
por: Owczarczyk-Saczonek, Agnieszka, et al.
Publicado: (2014)

Erythrodermic Psoriasis Improved by Ustekinumab: A Report of Two Cases
por: Kim, Ye Seul, et al.
Publicado: (2016)

Ustekinumab-induced amelioration of both palmoplantar psoriasis and psoriatic glossitis
por: Tonini, Annalisa, et al.
Publicado: (2019)

Listeria Meningitis in a Patient With Plaque Psoriasis on Ustekinumab Therapy
por: Roy, Moni, et al.
Publicado: (2022)

Efficacy of Brodalumab and Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis Who are Inadequate Responders to Ustekinumab: A Matching Adjusted Indirect Comparison
por: Hampton, Philip, et al.
Publicado: (2021)

Ustekinumab Drug Survival in Patients with Psoriasis: A retrospective Study of Real Clinical Practice
por: Galache Osuna, Cristina, et al.
Publicado: (2020)

Pustular Rash in Crohn's Patient on Ustekinumab Raises Concern for Drug-Induced Paradoxical Psoriasis
por: Barahimi, Mitra, et al.
Publicado: (2021)

Budget impact analysis of ustekinumab in the management of moderate to severe psoriasis in Greece
por: Avgerinou, Georgia, et al.
Publicado: (2012)

The use of ustekinumab in a patient with severe psoriasis and positive HBV serology()
por: Steglich, Raquel Bissacotti, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_a3pb1olrd5cpc4ldb0hboanp6v